7,9-dihydro-3H-purine-2,6,8-trione;1,3,7-trimethylpurine-2,6-dione

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: 7,9-dihydro-3H-purine-2,6,8-trione;1,3,7-trimethylpurine-2,6-dione
• 化学式: C13H14N8O5
• 分子量: 362.3
• InChiKey: SEFZGRHXCUTRIX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.8
• 重原子数：
  26
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  158
• 氢给体数：
  4
• 氢受体数：
  6

文献信息

• Kinetin/zeatin topical formulation
  申请人：Dow Pharmaceutical Sciences, Inc.

  公开号：US10166235B2

  公开（公告）日：2019-01-01

  The solubility of kinetin and/or of zeatin is increased when either or both are combined in a formulation that includes a polyoxyalkylene-n-glycerol dicarboxylate component and a fatty acid component. These two components provide a synergistic increase in the solubility of kinetin and/or zeatin that is greater than that which would be expected based on the solubility of kinetin and zeatin in the individual components.

  如果在配方中加入聚氧亚烷基-N-甘油二羧酸酯成分和脂肪酸成分，则可提高木犀草素和/或玉米素的溶解度。这两种成分协同提高了木犀草素和/或玉米素的溶解度，高于根据木犀草素和玉米素在单个成分中的溶解度预计的溶解度。
• US20140271826A1
  申请人：——

  公开号：US20140271826A1

  公开（公告）日：2014-09-18
• KINETIN/ZEATIN TOPICAL FORMULATION
  申请人：Dow Pharmaceutical Sciences, Inc.

  公开号：US20170209453A1

  公开（公告）日：2017-07-27

  The solubility of kinetin and/or of zeatin is increased when either or both are combined in a formulation that includes a polyoxyalkylene-n-glycerol dicarboxylate component and a fatty acid component. These two components provide a synergistic increase in the solubility of kinetin and/or zeatin that is greater than that which would be expected based on the solubility of kinetin and zeatin in the individual components.
• US9616132B2
  申请人：——

  公开号：US9616132B2

  公开（公告）日：2017-04-11
• US9925194B2
  申请人：——

  公开号：US9925194B2

  公开（公告）日：2018-03-27